stockrowAlbemarle Corporation
ALB Basic Materials Specialty Chemicals
Albemarle Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, down 4.37% from fiscal 2024.
- Revenue
- +18.8%
- EPS
- +225.6%
- Free cash flow
- +708.4%
- Total debt
- −48.1%
Quarter to September 2026, against a year earlier
Follow ALB
Alert me
Albemarle Corporation (ALB) Revenue
Albemarle Corporation's revenue for fiscal 2025 was $5.1B, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $6.2B. Over the past ten years it has ranged from $2.7B (fiscal 2016) to $9.6B (fiscal 2023); the current reading is higher than 73% of that period. Albemarle Corporation ranks 14th of 58 Specialty Chemicals companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $5.1B | (4.37%) |
| FY2024 | $5.4B | (44.08%) |
| FY2023 | $9.6B | 31.38% |
| FY2022 | $7.3B | 119.96% |
| FY2021 | $3.3B | 6.36% |
| FY2020 | $3.1B | (12.83%) |
| FY2019 | $3.6B | 6.35% |
| FY2018 | $3.4B | 9.86% |
| FY2017 | $3.1B | 14.75% |
| FY2016 | $2.7B | (5.28%) |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $1.6B | (10.91%) |
| Jun 2026 | $1.7B | 22.02% |
| Mar 2026 | $1.4B | 0.05% |
| Dec 2025 | $1.4B | 9.19% |
| 43 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| SSL Sasol Ltd. compare | $33.3B |
| WLK Westlake Corporation compare | $11.4B |
| EMN Eastman Chemical Company compare | $9.0B |
| SQM Sociedad Quimica y Minera S.A. compare | $8.5B |
| RPM RPM International Inc. compare | $8.0B |
| ALB Albemarle Corporation | $6.2B |
| AXTA Axalta Coating Systems Ltd. compare | $5.2B |
| SOLS Solstice Advanced Materials Inc. compare | $4.2B |
| ESI Element Solutions Inc. compare | $3.5B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on ALB
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement